Penumbra Inc (PEN)
201.84
-6.84
(-3.28%)
USD |
NYSE |
Apr 18, 16:00
201.90
+0.06
(+0.03%)
Pre-Market: 20:00
Penumbra Gross Profit Margin (Quarterly): 65.69% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 65.69% |
| September 30, 2023 | 65.59% |
| June 30, 2023 | 63.81% |
| March 31, 2023 | 62.58% |
| December 31, 2022 | 62.58% |
| September 30, 2022 | 63.33% |
| June 30, 2022 | 64.33% |
| March 31, 2022 | 62.49% |
| December 31, 2021 | 61.49% |
| September 30, 2021 | 63.07% |
| June 30, 2021 | 64.41% |
| March 31, 2021 | 65.80% |
| December 31, 2020 | 56.51% |
| September 30, 2020 | 60.18% |
| June 30, 2020 | 61.77% |
| March 31, 2020 | 64.09% |
| December 31, 2019 | 67.55% |
| September 30, 2019 | 68.81% |
| June 30, 2019 | 69.99% |
| Date | Value |
|---|---|
| March 31, 2019 | 65.33% |
| December 31, 2018 | 65.16% |
| September 30, 2018 | 67.09% |
| June 30, 2018 | 65.90% |
| March 31, 2018 | 64.81% |
| December 31, 2017 | 66.35% |
| September 30, 2017 | 65.28% |
| June 30, 2017 | 63.20% |
| March 31, 2017 | 65.16% |
| December 31, 2016 | 63.72% |
| September 30, 2016 | 63.81% |
| June 30, 2016 | 63.70% |
| March 31, 2016 | 68.90% |
| December 31, 2015 | 67.00% |
| September 30, 2015 | 66.44% |
| June 30, 2015 | 64.70% |
| March 31, 2015 | 68.62% |
| December 31, 2014 | 67.48% |
| September 30, 2014 | 64.06% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
56.51%
Minimum
Dec 2020
69.99%
Maximum
Jun 2019
63.90%
Average
63.81%
Median
Jun 2023
Gross Profit Margin (Quarterly) Benchmarks
| Stryker Corp | 63.68% |
| Boston Scientific Corp | 69.21% |
| Haemonetics Corp | 52.90% |
| Insulet Corp | 70.85% |
| Shockwave Medical Inc | 87.53% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 8.46% |
| Return on Assets | 6.30% |
| Return on Invested Capital | 8.46% |
| Profit Margin (Quarterly) | 19.05% |
| Operating Margin (Quarterly) | 12.30% |
| Return on Net Operating Assets | 8.30% |